CB
C. Frank Bennett is a scientist at Ionis Pharmaceuticals who has pioneered antisense oligonucleotide therapeutics. His work focuses on designing RNA-targeted drugs for neurological and other diseases, including treatments for spinal muscular atrophy and hereditary transthyretin amyloidosis. He has contributed to the clinical translation of oligonucleotide-based medicines.
- Field
- Medicine · Pharmacy and Pharmacology
- Clarivate categories
- Cross-Field
- Affiliation
- Ionis Pharmaceuticals Inc., United States